Imvaria
Pre-clinicalNoninvasive AI Biomarkers for better patient lives. Serving Fibresolve, the first FDA-authorized AI diagnostic tool in idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD)
Founded
2019
Focus
Diagnostics
About
Noninvasive AI Biomarkers for better patient lives. Serving Fibresolve, the first FDA-authorized AI diagnostic tool in idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD)
Funding History
2Total raised: $27.4M
Series A$24MNorthpond VenturesJun 15, 2023
Seed$3.4MUndisclosedOct 15, 2021
Company Info
TypePrivate
Founded2019
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile